These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
737 related articles for article (PubMed ID: 27325641)
21. MicroRNAs: Crucial Regulators of Stress. Roufayel R; Kadry S Microrna; 2020; 9(2):93-100. PubMed ID: 31241025 [TBL] [Abstract][Full Text] [Related]
22. The Enigma of miRNA Regulation in Cancer. Pradhan AK; Emdad L; Das SK; Sarkar D; Fisher PB Adv Cancer Res; 2017; 135():25-52. PubMed ID: 28882224 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA function in cancer: oncogene or a tumor suppressor? Shenouda SK; Alahari SK Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925 [TBL] [Abstract][Full Text] [Related]
24. OncomiRs: the discovery and progress of microRNAs in cancers. Cho WC Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887 [TBL] [Abstract][Full Text] [Related]
25. [Oncogenic and tumour suppressor microRNAs]. Finoux AL; Chartrand P Med Sci (Paris); 2008 Dec; 24(12):1049-54. PubMed ID: 19116113 [TBL] [Abstract][Full Text] [Related]
26. MicroRNAs and cancer: towards a personalized medicine. Fabbri M Curr Mol Med; 2013 Jun; 13(5):751-6. PubMed ID: 23642056 [TBL] [Abstract][Full Text] [Related]
27. The therapeutic potential of microRNAs in cancer. Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365 [TBL] [Abstract][Full Text] [Related]
28. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Mansoori B; Mohammadi A; Shirjang S; Baradaran B Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381 [TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance. Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-143 as a new weapon against cancer: overview of the mechanistic insights and long non-coding RNA mediated regulation of miRNA-143 in different cancers. Farooqi AA; Qureshi MZ; Attar R; Alhewairini SS; Fayyaz S; Sabitaliyevich UY; Duisenbayevich TM; Alaaeddine N Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):1-5. PubMed ID: 31472055 [TBL] [Abstract][Full Text] [Related]
31. MicroRNAs: small but potent oncogenes or tumor suppressors. Lee YS; Dutta A Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027 [TBL] [Abstract][Full Text] [Related]
32. Towards an extension of the two-variable model of carcinogenesis through oncogenes and tumour suppressor genes. Tourvas AD; Frangos CC Med Hypotheses; 2011 Dec; 77(6):956-8. PubMed ID: 21903334 [TBL] [Abstract][Full Text] [Related]
33. Anti-oncomir suppression of tumor phenotypes. Goga A; Benz C Mol Interv; 2007 Aug; 7(4):199-202, 180. PubMed ID: 17827440 [TBL] [Abstract][Full Text] [Related]
34. The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment. Uzuner E; Ulu GT; Gürler SB; Baran Y Methods Mol Biol; 2022; 2257():375-422. PubMed ID: 34432288 [TBL] [Abstract][Full Text] [Related]
36. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335 [TBL] [Abstract][Full Text] [Related]
37. OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs. Wang D; Gu J; Wang T; Ding Z Bioinformatics; 2014 Aug; 30(15):2237-8. PubMed ID: 24651967 [TBL] [Abstract][Full Text] [Related]
38. Modulation of cancer traits by tumor suppressor microRNAs. Grammatikakis I; Gorospe M; Abdelmohsen K Int J Mol Sci; 2013 Jan; 14(1):1822-42. PubMed ID: 23325049 [TBL] [Abstract][Full Text] [Related]
39. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Huang J; Zhang SY; Gao YM; Liu YF; Liu YB; Zhao ZG; Yang K Cell Prolif; 2014 Aug; 47(4):277-86. PubMed ID: 24909356 [TBL] [Abstract][Full Text] [Related]
40. Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs. Nguyen DD; Chang S Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]